SCHEMBL7242579

SCHEMBL7242579

C#CC(=O)Nc1ccc2ncnc(Nc3ccc(C(=O)c4ccccc4)cc3)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.67
ERBB2 P04626 6/20 0.67
ERBB4 Q15303 3/20 0.67
FYN P06241 4/20 0.58
SRC P12931 4/20 0.58
VCP P55072 1/20 0.55
TTBK1 Q5TCY1 1/20 0.53
TTBK2 Q6IQ55 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.53
HDAC3 O15379 1/20 0.52
HDAC1 Q13547 1/20 0.52
BTK Q06187 1/20 0.51
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPK1 P28482 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243671 0.86 EGFR (0.71) EGFRERBB2ERBB4FYNSRC
SCHEMBL7239048 0.83 FYN (0.85) EGFRERBB2ERBB4FYNSRC
SCHEMBL7235763 0.83 EGFR (0.73) EGFRERBB2ERBB4FYNSRC
SCHEMBL7128549 0.81 EGFR (0.65) EGFRERBB2ERBB4FYNSRC
SCHEMBL5565146 0.81 KDM4E (0.74) EGFRERBB2FYNSRCTTBK1
SCHEMBL2985038 0.80 EGFR (1.00) EGFRERBB2ERBB4FYNSRC
SCHEMBL27758514 0.80 FYN (0.70) EGFRERBB2FYNSRCVCP
SCHEMBL5569158 0.80 ABCG2 (0.69) EGFRERBB2ERBB4TTBK1TTBK2
SCHEMBL7243052 0.79 EGFR (0.60) EGFRERBB2ERBB4FYNSRC
Hydrochloric Acid SCHEMBL8809726 0.79 ABCG2 (0.68) EGFRERBB2ERBB4TTBK1TTBK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US claimed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
US-6562818-B1 For treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis WARNER-LAMBERT COMPANY 2003-05-13 US disclosed
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US disclosed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed